LimFlow SA: Funding, Investors & Team (Aug 2026)
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach.
LimFlow SA has raised $39.3M across 1 funding round on record, the most recent a Series D of $39.3M announced in Apr 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
LimFlow SA Company Profile and Key Stats
Latest funding round on record: Apr 2022.
LimFlow SA Funding Rounds
LimFlow SA Founders and Leadership Team
Contact details for the LimFlow SA team: 1 of 1 has an email address on file.
Start 14-day free trial →LimFlow SA Funding Compared to Other Health Care Startups
LimFlow SA's latest round of $39.3M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LimFlow SA in Health Care and Paris
Companies Similar to LimFlow SA
Beams is a producer of medical devices for cancerology based on the use of particles β.
Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…
CILcare specializes in providing drug solutions for hearing and ear disorders.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…
noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the…
Axomove is an e-wellbeing application that spends significant time in video actual activities.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…
May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…
MedinCell is an injectable slow-release drug specialist company.
Charles helps men regain control over their daily health concerns by starting with their personal health.
LimFlow SA Funding FAQs
What does LimFlow SA do?
LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularization efforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach.
How much funding has LimFlow SA raised?
LimFlow SA has raised $39.3M across 1 round on record. The most recent is a Series D of $39.3M announced in Apr 2022.
When did LimFlow SA last raise funding?
LimFlow SA's most recent funding round on record is a Series D of $39.3M, announced in Apr 2022.
Who is the CEO of LimFlow SA?
Dan Rose is listed as CEO at LimFlow SA.
Where is LimFlow SA headquartered?
LimFlow SA is based in Paris, Ile-De-France, France.
How many employees does LimFlow SA have?
LimFlow SA is in the 11-50 employee band.
How does LimFlow SA's funding compare to other Health Care startups?
LimFlow SA's latest round of $39.3M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's LimFlow SA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LimFlow SA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.